Lorazepam and other benzodiazepines are typically avoided when managing end-of-life agitated delirium in patients with cancer because these drugs can precipitate, even worsen, delirium. But a new ...
The addition of lorazepam to haloperidol reduced symptoms of agitated delirium among individuals with advanced cancers, according to study findings. The double blind randomized trial included 75 ...
The proportion of patients who needed rescue medication for breakthrough restlessness or agitation was significantly lower for patients who received lorazepam regimens than for those who received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results